Eli Lilly was joined by two other pharmaceutical companies in lowering the cost of insulin, NPR

More drug companies cut insulin prices this week. NPR’s Scott Simon talks with Kaiser Health News’ Bram Sable-Smith about what this means for patients.

Copyright © 2023 NPR. All rights reserved. For more information, visit our website terms of use and permissions pages at www.npr.org.

NPR transcripts are generated on a rush basis by an NPR contractor. This text may be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the transcript.

Source link